| Literature DB >> 22355284 |
Gaëlle Friocourt1, John G Parnavelas.
Abstract
Mutations in the homeobox transcription factor ARX have been found to be responsible for a wide spectrum of disorders extending from phenotypes with severe neuronal migration defects, such as lissencephaly, to mild forms of intellectual disabilities without apparent brain abnormalities, but with associated features of dystonia and epilepsy. Arx expression is mainly restricted to populations of GABA-containing neurons. Studies of the effects of ARX loss of function, either in humans or mutant mice, revealed varying defects, suggesting multiple roles of this gene in brain patterning, neuronal proliferation and migration, cell maturation and differentiation, as well as axonal outgrowth and connectivity. However, to date, little is known about how Arx functions as a transcription factor or which genes it binds and regulates. Recently, we combined chromatin immunoprecipitation and mRNA expression with microarray analysis and identified approximately 1000 gene promoters bound by Arx in transfected neuroblastoma N2a cells and mouse embryonic brain. To narrow the analysis of Arx targets to those most likely to control cortical interneuron migration and/or differentiation, we compare here our data to previously published studies searching for genes enriched or down-regulated in cortical interneurons between E13.5 and E15.5. We thus identified 14 Arx-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons. In this review, we present these genes and discuss how their possible regulation by Arx may lead to the dysfunction of GABAergic neurons, resulting in mental retardation and epilepsy.Entities:
Keywords: ARX; GABA; basal ganglia; epilepsy; interneurons; neuronal migration
Year: 2011 PMID: 22355284 PMCID: PMC3280452 DOI: 10.3389/fncel.2011.00028
Source DB: PubMed Journal: Front Cell Neurosci ISSN: 1662-5102 Impact factor: 5.505
List of candidate genes regulated by Arx and controlling cortical interneuron migration and/or differentiation
| Gene symbol | Gene name | Human CNS disease | Mouse endophenotype |
|---|---|---|---|
| Chemokine (C-X-C motif) receptor 7 | NA | Interneuron migration defects | |
| Meis homeobox 1 | Restless legs syndrome | NA | |
| Phosphatidic acid phosphatase type 2A | NA | NA | |
| Solute carrier family 12, member 5 | NA | Severe motor deficits | |
| E26 avian leukemia oncogene 2 | May contribute to Down syndrome | NA | |
| Pleckstrin homology-like domain, family A, member 1 | NA | NA | |
| Early growth response 1 | NA | Learning and memory defects | |
| Insulin-like growth factor 1 | Growth retardation, deafness, and mental retardation | Defects in neurologic development | |
| LIM domain only 3 | NA | NA | |
| Semaphorin 6A | NA | Impaired development of thalamocortical projections | |
| Leucine-rich repeat LGI family, member 1 | Lateral temporal epilepsy | Increased excitatory synaptic transmission | |
| Anaplastic lymphoma kinase | Susceptibility to neuroblastoma | NA | |
| Transforming growth factor, beta 3 | NA | NA | |
| NA | NA | ||
| High mobility group nucleosomal binding domain 3 | NA | NA | |
| LIM domain only 1 | NA | NA | |
| Early B-cell factor 3 | NA | Interneuron migration defects | |
| RasGEF domain family, member 1B | Candidate for the 4q21 deletion syndrome | NA | |
| Slit homolog 2 ( | NA | Abnormal axonal projections |
Examples of Arx-bound and regulated genes that are enriched in migrating cortical interneurons (IN) compared to neurons in ganglionic eminences (GE) and cortical non-interneurons (non-IN).
| Gene | Arx knock-out mice | Arx-transfected N2a cells | Expression in cortical migrating interneurons | ||
|---|---|---|---|---|---|
| ( | ( | Cells and stage | FC | Reference | |
| ↓ KO subpallium (FC = 1.6, | No specific change | IN > GE at E13.5 and E15.5 | 2.2–2.3 | ||
| No specific change | ↑ N2a cells (< 0.005) | GE > IN at E13.5 and E15.5 | 2.6–2.8 | ||
| IN > non-IN at E13.5 | 2.6 | ||||
| ↑ KO subpallium (FC = 1.4, | ↑ N2a cells ( | IN > non-IN at E13.5 | 2.2 | ||
| ↑ KO subpallium (FC = 1.8, | ↑ N2a cells ( | IN > non-IN at E13.5 and E15.5 | 7.7 | ||
| ↑ KO subpallium (FC = 1.8, | ↑ N2a cells ( | IN > non-IN at E13.5 | 2.7 | ||
| ↑ KO subpallium (FC = 2.2, | ↑ N2a cells ( | IN > non-IN at E13.5 and E15.5 | 3.2-3.7 | ||
| IN > non-IN at E14.5 | NA | ||||
| ↑ KO subpallium (FC = 3.1, | No specific change | IN > GE at E13.5 and E15.5 | 1.9–2.5 | ||
| IN > non-IN at E13.5 | 6.4 | ||||
| ↑ KO subpallium (FC = 1.5-5, | No specific change | IN > non-IN at E15.5 | 6.9 | ||
| ↑ KO subpallium (FC = 3.3, | No specific change | IN > non-IN at E14.5 | 6.9 | ||
| ↑ KO subpallium (FC = 1.6, | No specific change | IN > GE at E15.5 | 1.9 | ||
| No specific change | ↓ N2a cells ( | IN > non-IN at E13.5 and E15.5 | 2.7–26.2 | ||
| No specific change | ↓ N2a cells ( | IN > GE at E13.5 and E15.5 | 1.8–2.2 | ||
| IN > non-IN at E13.5 and E14.5 | 2.5 | ||||
| No specific change | ↓ N2a cells ( | IN > GE at E13.5 and E15.5 | 3.4–4.5 | ||
| IN > non-IN at E13.5 and E15.5 | 5.3-5.5 | ||||
| No specific change | ↓ N2a cells ( | IN > GE at E15.5 | 2 | ||
| IN > non-IN at E13.5 | 2.6-3 | ||||
Examples of Arx-bound and regulated genes that are down-regulated in migrating cortical interneurons (IN) compared to neurons in the ganglionic eminences (GE) and cortical non-interneurons (non-IN).
| Gene | Arx knock-out mice ( | Arx-transfected N2a cells | Expression in cortical migrating interneurons | ||
|---|---|---|---|---|---|
| ( | Cells and stage | FC | Reference | ||
| ↓ KO subpallium (FC = 1.3, | No specific change | GE >IN at E15.5 | 2.1 | ||
| Non-IN > IN at E13.5 | 2.6-2.9 | ||||
| ↑ KO subpallium (FC = 1.6, | ↓ N2a cells ( | GE > IN at E13.5 and E15.5 | 3.0–5.3 | ||
| Non-IN > IN at E13.5 and E15.5 | 3.3-5.6 | ||||
| ↓ KO subpallium (FC = 1.6, | No specific change | GE > IN at E13.5 and E15.5 | 2.0–2.3 | ||
| Non-IN > IN at E13.5 | 5.5 | ||||
| ↑ KO subpallium ( | No specific change | GE > IN at E13.5 | 3 | ||
| Non-IN > IN at E14.5 | NA | ||||
| ↑ KO subpallium (FC = 1.4, | No specific change | GE > IN at E13.5 and E15.5 | 2.1–2.2 | ||
| Non-IN > IN at E13.5 | 3.5 | ||||